...
首页> 外文期刊>Psychogeriatrics : >Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review
【24h】

Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review

机译:帕金森氏症的抑郁症:药物治疗的有效性和风险。临床评论

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Parkinson's disease (PD) is a neurological disease with a heterogeneous pattern of neurological symptoms and concomitant psychiatric syndromes. These syndromes are triggered by alterations to neurotransmission that are likely common for both neurological and psychiatric symptoms. Syndromes such as depression, anxiety, or cognitive impairment can precede motor symptoms of PD and delay its diagnosis. Recently, questions related to aetiological factors and treatment strategies of depression in PD have become a growing concern of PD researchers. This article describes the main features of depression in PD and presents current hypotheses on its aetiology and recommended treatment modes.
机译:帕金森氏病(PD)是一种神经病,具有多种神经症状和伴随的精神病综合症。这些综合征是由神经传导改变引起的,这可能是神经和精神症状都常见的。诸如抑郁症,焦虑症或认知障碍等综合征可先于PD的运动症状出现,并延迟其诊断。最近,与PD的病因和抑郁症的治疗策略有关的问题已成为PD研究人员日益关注的问题。本文介绍了PD抑郁症的主要特征,并就其病因和推荐的治疗方式提出了当前的假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号